Sanofi, GSK get Indian approval for late-stage trial of Covid-19 vaccine

The Indian arm of the studies will enrol roughly 3,000 adults between the ages of 18 years and 55 years, according to India's clinical trial registry.

from Latest News https://ift.tt/3hO9EDW
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share